2706. Effectiveness and Safety of Shingrix Vaccination in Solid Organ Transplant Recipients at a Large Urban Transplant Center

BACKGROUND: The varicella zoster virus (VZV) recombinant subunit vaccine, Shingrix, was found to be safe in solid organ transplant recipients (SOTR) and is now approved and recommended for all immunocompromised patients. Given limited efficacy data, we preferred a single center retrospective study t...

Descripción completa

Detalles Bibliográficos
Autores principales: Halkett, Megan, Ison, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679076/
http://dx.doi.org/10.1093/ofid/ofad500.2317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679076/
http://dx.doi.org/10.1093/ofid/ofad500.2317

Ejemplares similares